Hydroxyl safflower yellow B combined with doxorubicin inhibits the proliferation of human breast cancer MCF-7 cells

Doxorubicin (DOX) is currently the preferred chemotherapeutic agent for breast cancer, and hydroxyl safflower yellow B (HSYB) has a tumor growth-inhibiting activity. The present study aimed to investigate the effects of HSYB combined with DOX on the proliferation of human breast cancer MCF-7 cells a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Kehao, Qin, Ze, Qu, Chuanjun, Chen, Xiaoyu, Jiang, Qingling, Li, Minjing, Zheng, Qiusheng, Li, Defang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025109/
https://www.ncbi.nlm.nih.gov/pubmed/33850567
http://dx.doi.org/10.3892/ol.2021.12687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025109/
https://www.ncbi.nlm.nih.gov/pubmed/33850567
http://dx.doi.org/10.3892/ol.2021.12687

Ejemplares similares